Tretinoin 10 MG Oral Capsule — RxCUI 199159
RxNorm drug concept · Semantic clinical drug
RxCUI 199159
Semantic clinical drug · SCD
● Current RxNorm concept 5 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI199159
Official nameTretinoin 10 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped5
Package NDCs mapped6
Reported Medicaid activity (SDUD)277 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tretinoin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Honestly, it won't erase wrinkles — and the label is pretty direct about that. What it's approved to do is help reduce the appearance of fine wrinkles as part of a full routine tha...
- Will tretinoin actually get rid of my wrinkles?
- Redness, peeling, and irritation in the first couple of weeks are very common and usually mean your skin is adjusting — not that something is wrong. If it's tolerable, try hanging...
- My skin is really red and peeling after the first week — should I stop?
🕸️ Concept Web — How Tretinoin 10 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tretinoin 10 MG Oral Capsule
RxCUI 199159 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Tretinoin
10753IN
-
Tretinoin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tretinoin Oral Capsule
374187SCDF -
Tretinoin Oral Product
1157684SCDG -
Tretinoin Pill
1158219SCDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Tretinoin Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tretinoin 10 MG
316850SCDC
-
Tretinoin 10 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tretinoin 10 MG
SCDC · 316850 -
Tretinoin Oral Capsule
SCDF · 374187 -
Tretinoin Oral Product
SCDG · 1157684 -
Tretinoin Pill
SCDG · 1158219
📦 FDA Products & Package NDCs
5 products · 6 package NDCs
6 package NDCs map to RxCUI 199159 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00904-6867-04 | 30 BLISTER PACK in 1 CARTON (0904-6867-04) / 1 CAPSULE in 1... | Tretinoin | Major Pharmaceuticals | 2012-10-24 |
| 10370-0268-01 | 100 CAPSULE in 1 BOTTLE (10370-268-01) | Tretinoin | Par Health USA, LLC | 2012-10-24 |
| 68084-0075-21 | 3 BLISTER PACK in 1 CARTON (68084-075-21) / 10 CAPSULE in 1... | Tretinoin | American Health Packaging | 2013-07-18 |
| 68462-0792-01 | 100 CAPSULE in 1 BOTTLE (68462-792-01) | Tretinoin | Glenmark Pharmaceuticals Inc., USA | 2016-12-23 |
| 72162-1220-01 | 100 CAPSULE in 1 BOTTLE (72162-1220-1) | Tretinoin | Bryant Ranch Prepack | 2024-02-09 |
| 72162-1220-03 | 30 CAPSULE in 1 BOTTLE (72162-1220-3) | Tretinoin | Bryant Ranch Prepack | 2024-02-09 |
Observed labelers:
Bryant Ranch Prepack (2) ·
American Health Packaging (1) ·
Glenmark Pharmaceuticals Inc., USA (1) ·
Major Pharmaceuticals (1) ·
Par Health USA, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$9.4862
Range $9.4862–$9.4862
· middle 50% $9.4862–$9.4862
· 4 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.